Neuronetics Inc (NASDAQ:STIM) price on Friday, March 21, fall -1.62% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $4.86.
A look at the stock’s price movement, the close in the last trading session was $4.94, moving within a range at $4.772 and $4.92. The beta value (5-Year monthly) was 2.072. Turning to its 52-week performance, $5.92 and $0.52 were the 52-week high and 52-week low respectively. Overall, STIM moved 1.25% over the past month.
Neuronetics Inc’s market cap currently stands at around $194.73 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-03.
Analysts have a consensus estimate of 29.07M for the company’s revenue for the quarter, with a low and high estimate of 28.57M and 29.9M respectively. The average forecast suggests up to a 66.89% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 148.57M, representing a 99.43% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that STIM is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 2 recommend STIM as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
STIM’s current price about 3.45% and 28.99% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 56.37, while 7-day volatility ratio is 7.40% and 12.39% in the 30-day chart. Further, Neuronetics Inc (STIM) has a beta value of 1.84, and an average true range (ATR) of 0.49. Analysts have given the company’s stock an average 52-week price target of $8, forecast between a low of $8 and high of $8. Looking at the price targets, the low is -64.61% off current price level while to achieve the yearly target high, price needs to move -64.61%. Nonetheless, investors will most likely welcome a -64.61% jump to $8 which is the analysts’ median price.
If we refocus on Neuronetics Inc (NASDAQ:STIM), historical trading data shows that trading volumes averaged 1.01 over the past 10 days and 1.53 million over the past 3 months. The company’s latest data on shares outstanding shows there are 55.68 million shares.
The 78.65% of Neuronetics Inc’s shares are in the hands of company insiders while institutional holders own 18.84% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 1.99 million on 2025-02-28, giving us a short ratio of 0.97. The data shows that as of 2025-02-28 short interest in Neuronetics Inc (STIM) stood at 315.0 of shares outstanding, with shares short rising to 1.28 million registered in 2025-01-31. Current price change has pushed the stock 201.86% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the STIM stock continues to rise going into the next quarter.
